lilly verve therapeutics - Search News

Order byBest matchMost fresh

News

Eli Lilly nears $1.3B deal for Verve Therapeutics

· 5h · on MSN

Eli Lilly to Acquire Verve Therapeutics for Up to $1.3 Billion

Eli Lilly agreed to acquire Verve Therapeutics for about $1 billion upfront, adding a potential treatment for cardiovascular disease to its portfolio.Under the agreement, the pharmaceutical company will buy all of the gene-editing startup’s shares outstanding for $10.

Continue reading

· 7h · on MSN

Eli Lilly’s $1.3 Billion Bid Sends Verve Therapeutics Stock Soaring. What to Know.

· 3h · on MSN

Eli Lilly Co. to buy gene-editing startup Verve to develop cardiac drugs

11h

Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk

Eli Lilly and Company (NYSE: LLY) and Verve Therapeutics, Inc. (Nasdaq: VERV), a Boston-based clinical-stage company ...

7hon MSN

This one-and-done heart-disease treatment just got a $1.3 billion endorsement from Eli Lilly

Verve Therapeutics’ stock was rallying by a record 80% on Eli Lilly’s premium purchase price for the drug-development company ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results